73
Participants
Start Date
April 20, 2021
Primary Completion Date
November 22, 2022
Study Completion Date
December 13, 2022
Low dose ADP101
Active powder formulation
High dose ADP101
Active powder formulation.
Pooled Placebo
Placebo powder
Study Site, Philadelphia
Study Site, Chapel Hill
Study Site, Charleston
Study Site, Marietta
Study Site, Atlanta
Study Site, Tampa
Study Site, Cincinnati
Study Site, Ann Arbor
Study Site, Normal
Study Site, Denver
Study Site, Rolling Hills Estates
Study Site, San Diego
Study Site, Mission Viejo
Study Site, Happy Valley
Study Site, Seattle
Lead Sponsor
Alladapt Immunotherapeutics, Inc.
INDUSTRY